Endocrinological Issues

  • Aidan McElduff
  • Neha Bansal


Endocrinology involves the study of the problems which result from disruption of the hormonal system. Such problems particularly affect the intellectually disabled population. This chapter will review the endocrine and related disorders which are commonly seen in adults with intellectual disability. These include, thyroid disease (hypothyroidism, hyperthyroidism), diabetes, sex hormone issues, osteoporosis. Care provision will be discussed.


Endocrinology Hormones Thyroid disease Diabetes Vitamin Hypogonadism Menopause Osteoporosis Screening Care delivery 


  1. 1.
    Chrousos GP. Stress, chronic inflammation, and emotional and physical well-being: concurrent effects and chronic sequelae. J Allergy Clin Immunol. 2000;106(Suppl 5):S275–91.CrossRefGoogle Scholar
  2. 2.
    Beange H, McElduff A, Baker W. Medical disorders in adults with intellectual disability: a population study. Am J Ment Retard. 1995a;99:595–604.PubMedGoogle Scholar
  3. 3.
    Evenhuis H, Henderson CM, Beange H, Lennox N, Chicoine B. Healthy ageing—Adults with intellectual disabilities: Physical health issues. Geneva: World Health Organization; 2001.Google Scholar
  4. 4.
    World Health Organisation. Healthy ageing adults with intellectual disabilities. Background reports on physical and mental health, women's health and ageing and social policy. physical health issues. Geneva: World Health Organization; 2000.Google Scholar
  5. 5.
    World Health Organisation. Population-based approaches to childhood obesity prevention. Geneva: World Health Organisation; 2012.Google Scholar
  6. 6.
    De Winter CF, Bastiaanse LP, Hilgenkamp TI, Evenhuis HM, Echteld MA. Overweight and obesity in older people with intellectual disability. Res Dev Disabil. 2012;33(2):398–405. PubMed PMID: 22119687CrossRefPubMedGoogle Scholar
  7. 7.
    Gawlik K, Zwierzchowska A, Rosolek B, Celebanska D, Moczek K. Obesity among adults with moderate and severe intellectual disabilities. Adv Rehabil. 2016;30:17–25. Scholar
  8. 8.
    Hsieh K, Rimmer JH, Heller T. Obesity and associated factors in adults with intellectual disability. J Intellect Disabil Res. 2014;58:851–63. PubMed PMID: 24256455CrossRefGoogle Scholar
  9. 9.
    Krause S, Ware R, McPherson L, Lennox N, O'Callaghan M. Obesity in adolescents with intellectual disability: Prevalence and associated characteristics. Obes Res Clin Pract. 2016;10:520–30. Scholar
  10. 10.
    Phillips KL, Schieve LA, Visser S, Boulet S, Sharma AJ, Kogan MD, Boyle AC, Yeargin-Allsopp M. Prevalence and impact of unhealthy weight in a national sample of US adolescents with autism and other learning and behavioral disabilities. Matern Child Health J. 2014;18:1964–75. Scholar
  11. 11.
    Rimmer JH, Yamaki K. Obesity and intellectual disability. Ment Retard Dev Disabil Res Rev. 2006;12:22–7. ReviewCrossRefGoogle Scholar
  12. 12.
    Emerson E, Robertson J, Baines S, Hatton C. Obesity in British children with and without intellectual disability: cohort study. BMC Public Health. 2016;16:644. Scholar
  13. 13.
    Prasher VP. Overweight and obesity amongst down syndrome adults. J Intellect Disabil Res. 1995;39:437–41.CrossRefGoogle Scholar
  14. 14.
    Spanos D, Melville CA, Hankey CR. Weight management interventions in adults with intellectual disabilities and obesity: a systematic review of the evidence. Nutr J. 2013;12:132. ReviewCrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Beange H, Gale L, Stewart L. Project Renourish: a dietary intervention to improve nutritional status in people with multiple disabilities. Aust N Z J Dev Disabil. 1995b;20:165–74.Google Scholar
  16. 16.
    Kuperminc MN, Stevenson RD. Growth and nutrition disorders in children with cerebral palsy. Dev Disabil Res Rev. 2008;14:137–46. Scholar
  17. 17.
    Waber DP, Bryce CP, Girard JM, Zichlin M, Fitzmaurice GM, Galler JR. Impaired IQ and academic skills in adults who experienced moderate to severe infantile malnutrition: a forty-year study. Nutr Neurosci. 2014;17:58–64. Scholar
  18. 18.
    Groce N, Challenger E, Berman-Bieler R, Farkas A, Yilmaz N, Schultink W, Clark D, Kaplan C, Kerac M. Malnutrition and disability: unexplored opportunities for collaboration. Paediatr Int Child Health. 2014;34(4):308–14. Scholar
  19. 19.
    Prasher VP. Down syndrome and thyroid disorders: a review. Down Syndr Res Pract. 1999;6:105–10.CrossRefGoogle Scholar
  20. 20.
    Aversa T, Lombardo F, Valenzise M, Messina MF, Sferlazzas C, Salzano G, De Luca F, Wasniewska M. Peculiarities of autoimmune thyroid diseases in children with Turner or Down syndrome: an overview. Ital J Pediatr. 2015;41:39. Scholar
  21. 21.
    Iughetti L, Predieri B, Bruzzi P, Predieri F, Vellani G, Madeo SF, Garavelli L, Biagioni O, Bedogni G, Bozzola M. Ten-year longitudinal study of thyroid function in children with Down syndrome. Horm Res Paediatr. 2014;82:113–21. Scholar
  22. 22.
    Cebeci AN, Güven A, Yildiz M. Profile of hypothyroidism in Down’s syndrome. J Clin Res Pediatr Endocrinol. 2013;5(2):116–20. Scholar
  23. 23.
    Léger J. Congenital hypothyroidism: a clinical update of long-term outcome in young adults. Eur J Endocrinol. 2015;172:R67–77. Scholar
  24. 24.
    Marques I, Silva A, Castro S, Lopes L. Down syndrome, insulin-dependent diabetes mellitus and hyperthyroidism: a rare association. BMJ Case Rep. 2015. pii: bcr2014208166. doi: PubMed PMID: 26123455; PubMed Central PMCID: PMC4488676.
  25. 25.
    Shaw JE, Dunstan DW, Zimmet PZ, Cameron AJ, de Courten MP, Welborn TA. Epidemic glucose intolerance in Australia. Proceedings of the 37th Annual Meeting of the European Association for the Study of Diabetes. 2001. Abstract 9.Google Scholar
  26. 26.
    Axmon A, Ahlström G, Höglund P. Prevalence and treatment of diabetes mellitus and hypertension among older adults with intellectual disability in comparison with the general population. BMC Geriatr. 2017;17:272. Scholar
  27. 27.
    World Health Organisation. Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus: Abbreviated report of a WHO consultation. Geneva: World Health Organization; 2011.Google Scholar
  28. 28.
    Adler AI, Stratton IM, Neil HA, Yudkin JS, Matthews DR, Cull CA, Wright AD, Turner RC, Holman RR. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. Br Med J. 2000;321:394–5.CrossRefGoogle Scholar
  29. 29.
    UK Prospective Diabetes Study Group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. Br Med J. 1998;317:713–20.CrossRefGoogle Scholar
  30. 30.
    Cardol M, Rijken M, van Schrojenstein Lantman-de Valk H. People with mild to moderate intellectual disability talking about their diabetes and how they manage. J Intellect Disabil Res. 2012;56:351–60. Scholar
  31. 31.
    Anwar AJ, Walker JD, Frier BM. Type 1 diabetes mellitus and Down’s syndrome: prevalence, management and diabetic complications. Diabet Med. 1998;15:160–3.CrossRefGoogle Scholar
  32. 32.
    Diabetes Prevention Program (DPP) [missing title]. 2001. Accessed from
  33. 33.
    Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Aunola S, Cepaitis Z, Moltchanov V, Hakumaki M, Mannelin M, Martikkala V, Sundvall J, Uusitupa M, the Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343–50.CrossRefGoogle Scholar
  34. 34.
    Frighi V, Morovat A, Stephenson MT, White SJ, Hammond CV, Goodwin GM. Vitamin D deficiency in patients with intellectual disabilities: prevalence, risk factors and management strategies. Br J Psychiatry. 2014;205:458–64. PubMed PMID: 25257061CrossRefPubMedGoogle Scholar
  35. 35.
    Grant WB, Wimalawansa SJ, Holick MF, Cannell JJ, Pludowski P, Lappe JM, Pittaway M, May P. Emphasizing the health benefits of vitamin D for those with neurodevelopmental disorders and intellectual disabilities. Nutrients. 2015;7:1538–64. Scholar
  36. 36.
    Wark JD, Larkins RG, Perry KD, Peter CT, Ross DL, Sloman JG. Chronic diphenylhydantoin therapy does not reduce plasma 25hydroxyvitamin D. Clin Endocrinol (Oxf). 1979;11:267–74.CrossRefGoogle Scholar
  37. 37.
    Meier C, Kraenzlin ME. Antiepileptics and bone health. Ther Adv Musculoskelet Dis. 2011;3:235–43. Scholar
  38. 38.
    Menon B, Harinarayan CV. The effect of anti-epileptic drug therapy on serum 25hydroxyvitamin D and parameters of calcium and bone metabolism–a longitudinal study. Seizure. 2010;19:153–8. Epub 2010 Feb 7CrossRefPubMedGoogle Scholar
  39. 39.
    Mintzer S, Boppana P, Toguri J, DeSantis A. Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine. Epilepsia. 2006;47:510–5.CrossRefGoogle Scholar
  40. 40.
    Pack AM, Morrell MJ, Randall A, McMahon DJ, Shane E. Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy. Neurology. 2008;70:1586–93.CrossRefGoogle Scholar
  41. 41.
    Santen FJ. Male hypogonadism. In: SSC Y, Jaffe RB, editors. Reproductive endocrinology. 3rd ed. Philadelphia, PA: WB Saunders Co.; 1991. p. 745–000.Google Scholar
  42. 42.
    McElduff A, Center J, Beange H. Hypogonadism in men with intellectual disabilities: a population study. J Intellect Dev Disabil. 2003;28:163–70.CrossRefGoogle Scholar
  43. 43.
    Lip SZL, Murchison LED, Cullis PS, Govan L, Carachi R. A meta-analysis of the risk of boys with isolated cryptorchidism developing testicular cancer in later life. Arch Dis Child. 2013;98:20–6.CrossRefGoogle Scholar
  44. 44.
    Cortes D, Visfeldt J, Moller H, Thorup J. Testicular neoplasia in cryptorchid boys at primary surgery: case series. Br Med J. 1999;319:888–9.CrossRefGoogle Scholar
  45. 45.
    Satge D, Sasco AJ, Cure H, Leduc B, Sommelet D, Vekemans MJ. An excess of testicular germ cell tumors in Down's syndrome: three case reports and a review of the literature. Cancer. 1997;80:929–35.CrossRefGoogle Scholar
  46. 46.
    Cortada X, Kousseff BG. Cryptorchidism in mental retardation. J Urol. 1984;131:674–6.CrossRefGoogle Scholar
  47. 47.
    Haire AR, Flavill J, Groom WD, Dhandapani B. Unidentified undescended testes in teenage boys with severe learning disabilities. Arch Dis Child. 2015;100:479–80. Epub 2015 Feb 2. ReviewCrossRefPubMedGoogle Scholar
  48. 48.
    McCarthy M. Going through the menopause: perceptions and experiences of women with intellectual disability. J Intellect Dev Disabil. 2002;27:281–95.CrossRefGoogle Scholar
  49. 49.
    Ejskjaer K, Uldbjerg N, Goldstein H. Menstrual profile and early menopause in women with Down syndrome aged 26-40 years. J Intellect Dev Disabil. 2006;31:166–71.CrossRefGoogle Scholar
  50. 50.
    Seltzer GB, Schupf N, Wu H-S. A prospective study of menopause in women with Down's syndrome. J Intellect Disabil Res. 2001;45:1–7. Scholar
  51. 51.
    Consensus Development Conference. Diagnosis, prophylaxis and treatment of osteoporosis. Am J Med. 1993;94:646–50.CrossRefGoogle Scholar
  52. 52.
    Center J, Beange H, McElduff A. People with mental retardation have an increased prevalence of osteoporosis: a population study. Am J Ment Retard. 1998;103:19–28.CrossRefGoogle Scholar
  53. 53.
    Srikanth R, Cassidy G, Joiner C, Teeluckdharry S. Osteoporosis in people with intellectual disabilities: a review and a brief study of risk factors for osteoporosis in a community sample of people with intellectual disabilities. J Intellect Disabil Res. 2011;55:53–62. Scholar
  54. 54.
    Kao CH, Chen CC, Wang SJ, Yeh SH. Bone mineral density in children with Down syndrome detected by dual photon absorptiometry. Nucl Med Commun. 1992;13:773–5.CrossRefGoogle Scholar
  55. 55.
    Sepúlveda D, Allison DB, Gomez JE, Kreibich K, Brown RA, Pierson RN, Heymsfield SB. Low spinal and pelvic bone mineral density among individuals with Down syndrome. Am J Ment Retard. 1995;100:109–14.PubMedGoogle Scholar
  56. 56.
    Petrone LR. Osteoporosis in adults with intellectual disabilities. South Med J. 2012;105:87–92. ReviewCrossRefPubMedGoogle Scholar
  57. 57.
    Tannenbaum TN, Lipworth L, Baker S. Risk of fractures in an intermediate care facility for persons with mental retardation. Am J Ment Retard. 1989;95:444–51.Google Scholar
  58. 58.
    Hsieh K, Rimmer J, Heller T. Prevalence of falls and risk factors in adults with intellectual disability. Am J Intellect Dev Disabil. 2012;117(6):442–54. Scholar
  59. 59.
    Spreat S, BakerPotts JC. Patterns of injury in institutionalized mentally retarded residents. Ment Retard. 1983;21:23–9.PubMedGoogle Scholar
  60. 60.
    Johnston CC, Slemenda CW, Melton LJ. Clinical use of bone densitometry. N Engl J Med. 1991;324:1105–9.CrossRefGoogle Scholar
  61. 61.
    Dreyfus D, Lauer E, Wilkinson J. Characteristics associated with bone mineral density screening in adults with intellectual disabilities. J Am Board Fam Med. 2014;27:104–14. Scholar
  62. 62.
    Eastell R, Boyle IT, Compston J, Cooper C, Fogelman I, Francis RM, Hosking DJ, Purdie DW, Ralston S, Reeve J, Reid DM, Russell RGG, Stevenson JC. Management of male osteoporosis: report of the UK Consensus Group. Q J Med. 1998;91:71–92.CrossRefGoogle Scholar
  63. 63.
    Meunier PJ, Delmas PD, Eastell MR, Papapoulos S, Rizzoli R, Seeman E, Wasnick RD. Diagnosis and management of osteoporosis in postmenopausal women: Clinical guidelines. Clin Ther. 1999;21:1025–39.CrossRefGoogle Scholar
  64. 64.
    Tinetti ME, Baker DI, McAvay G, Claus EG, Garrett P, Gottschalk M, Koch ML, Trainor K, Horwitz RI. A multifactorial intervention to reduce the risk of falling among elderly people living in the community. N Engl J Med. 1994;331:821–7.CrossRefGoogle Scholar
  65. 65.
    De Winter CF, Magilsen KW, van Alfen JC, Willemsen SP, Evenhuis HM. Metabolic syndrome in 25% of older people with intellectual disability. Fam Pract. 2011;28(2):141–4. PubMed PMID: 20937662CrossRefPubMedGoogle Scholar
  66. 66.
    De Winter CF, Magilsen KW, van Alfen JC, Penning C, Evenhuis HM. Prevalence of cardiovascular risk factors in older people with intellectual disability. Am J Intellect Dev Disabil. 2009;114:427–36. PubMed PMID: 19792058CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Aidan McElduff
    • 1
  • Neha Bansal
    • 2
  1. 1.Discipline of MedicineUniversity of SydneyCamperdownAustralia
  2. 2.Greenfields, Birmingham Community NHS TrustBirminghamUK

Personalised recommendations